Senior Consultant, Clinical Operations & Clinical Development - USA at Elixir Associates
Exciting Development in Heart Health Care ?? The FDA has recently granted clearance to Omron Healthcare's innovative wearable device, adding a revolutionary feature to its at-home blood pressure cuffs. This device can now screen for atrial fibrillation (afib) using AI-powered software, even without relying on electrical signals. ???? Afib detection can be a game-changer in preventing strokes and heart attacks, especially as it's often under-diagnosed. Omron's new technology achieves an impressive 95% sensitivity and 98% specificity, according to a recent clinical trial published in the Heart Rhythm Journal. This advancement underscores the critical role of regular health monitoring in managing hypertension and afib, which affects many U.S. adults. #HealthcareInnovation #AIinMedicine #HeartHealth
